This Phase III trial investigates if the incorporation of immunotherapy will improve progression-free survival (PFS) and maintain overall survival (OS) while simultaneously minimizing long-term morbidity and treatment-related mortality by reducing exposure to radiotherapy and high cumulative chemotherapy doses. The study will enroll patients ages 5 to 60…
We are looking to recruit women (ages 18-40) who have problems sleeping to help with the development of an artificial intelligence-based tool that will help improve sleep among young women. The study includes two parts. Participants will be compensated $150 for completing the first part of the study and $75 for completing the second part. The first part of…